Global Intra-Aortic Balloon Pump (IABP) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Intra-Aortic Balloon Pump (IABP) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Intra-aortic balloon pump (IABP) is a cardiovascular medical device for temporarily improving cardiac function in human in life-threatening surgeries such as heart transplant, percutaneous coronary interventions and coronary artery bypass grafting. Intra-aortic balloon pump (IABP) is further used in cardiogenic shock and assisting left ventricular function. Intra-aortic balloon pump (IABP) consists two main components as, a double-lumen catheter with a distal end located inflatable bubble and a console that regulates the inflation and deflation of the balloon.

Market Overview:

The latest research study on the global Intra-Aortic Balloon Pump (IABP) market finds that the global Intra-Aortic Balloon Pump (IABP) market reached a value of USD 458.45 million in 2022. It’s expected that the market will achieve USD 577.12 million by 2028, exhibiting a CAGR of 3.91% during the forecast period.

Market Opportunities

The government in a relatively stable political region has the ability to encourage the development of Intra-Aortic Balloon Pump (IABP) industry, and the United States has signed the latest expenditure agreement, announcing the formal abolition of the consumption tax on medical devices. China's medical device regulatory policy is more perfect. On August 26, 2019, China Food and Drug Administration issued the Rules of Unique Identification System for Medical Devices, aiming at implementing the Notice of the General Office of the State Council on Printing and Distributing the Reform Plan for the Treatment of High-value Medical Consumables and the Regulations on the Supervision and Administration of Medical Devices, further strengthening the supervision and management of the whole life cycle of medical devices, and innovating the supervision mode. Good political environment will promote the development of Intra-Aortic Balloon Pump (IABP) industry.

Market Risk

Because the device is placed in the femoral artery and aorta, it may cause ischemia and compartment syndrome. If the femoral artery it supplies is blocked, the risk of leg ischemia is highest. Placing the balloon too far away from the aortic arch may lead to renal artery occlusion and subsequent renal failure. Other possible complications include cerebral embolism during insertion, infection, dissection of aorta or iliac artery, arterial perforation and mediastinal hemorrhage. Mechanical failure of balloon itself is also a risk, in which case vascular surgery is needed to remove it. After the balloon is removed, the micro-clots formed on the balloon surface are also at risk of embolism shower, which may lead to peripheral thrombosis, myocardial ischemia, hemodynamic decompensation and advanced pseudoaneurysm.

Region Overview:

North America had the highest growth rate of all regions.

Company Overview:

Maquet (Getinge Group),Teleflex Incorporated and Senko Medical Instrument Manufacturing are the five key players in the global Intra-Aortic Balloon Pump (IABP) market. These companies have shown consistent growth in revenue, larger volumes of sales and a prominent presence in terms of share in the global Intra-Aortic Balloon Pump (IABP) market in the past 5 years.

Getinge is a global medical technology company, founded in Sweden in 1904. The firm provides equipment and systems within healthcare and life sciences. The company was formerly organised in three business areas: Infection Control (trading as Getinge), Extended Care (ArjoHuntleigh) and Medical Systems (Maquet, the world's largest maker of surgical tables), but announced it would become a single brand company, operating under the brand Getinge, on 20 March 2017.

Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. Its portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch®, UroLift® and Weck® - trusted brands united by a common sense of purpose.

Segmentation Overview:

By type, Fiber Optic Type segment accounted for the largest share of market in 2021.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Intra-Aortic Balloon Pump (IABP) market covered in Chapter 3:

Teleflex Incorporated
Maquet (Getinge Group)
Senko Medical Instrument Manufacturing

In Chapter 4 and Chapter 14.2, on the basis of types, the Intra-Aortic Balloon Pump (IABP) market from 2018 to 2029 is primarily split into:

Fiber Optic Type
Ordinary Type

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Intra-Aortic Balloon Pump (IABP) market from 2018 to 2029 covers:

Hospitals
Cardiac Care Centers
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)